BPC-157 (Body Protection Compound-157): A synthetic peptide derived from a natural gastric protein
For optimal and safe outcomes, always follow professional guidance and recommended dosage.
In addition, identification of novel differences between eryptotic and apoptotic lethal subroutines might expand our opportunities to discover selectively targetable pathways for therapeutics to modulate eryptosis
doi: 10.3389/fneur.2020.00267 35
PendersJGerholdKStobberinghEEThijsCZimmermannKLauSet al
Theoretically, BPC-157 shows faster onset (4-6 days in animal models vs 2-6 weeks for human SSRIs), multi-system modulation rather than single-target effects, actual neuronal repair and regeneration (neuroprotection), no withdrawal syndrome in animals, and efficacy when given peripherally without extensive blood-brain barrier crossing